Evaluation and management of post-LASIK dry eye syndrome

International Ophthalmology Clinics

Volumn 50, Issue 3, 2010, Pages 191-199

  Rosenfeld, Steven I ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; CYCLOSPORIN; EYE DROPS; IMMUNOSUPPRESSIVE AGENT;

CLINICAL EVALUATION; DISEASE SEVERITY; DRY EYE; HUMAN; KERATOMILEUSIS; PATHOPHYSIOLOGY; PATIENT IDENTIFICATION; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; REVIEW; RISK FACTOR; DIET SUPPLEMENTATION; DRY EYE SYNDROMES; POSTOPERATIVE CARE; PROCEDURES; TREATMENT OUTCOME;

CYCLOSPORINE; DIETARY SUPPLEMENTS; DRY EYE SYNDROMES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KERATOMILEUSIS, LASER IN SITU; OPHTHALMIC SOLUTIONS; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; TREATMENT OUTCOME;

EID: 77954625741     PISSN: 00208167     EISSN: None     Source Type: Journal    
DOI: 10.1097/IIO.0b013e3181e2469b     Document Type: Review

References (17)

1. Behrens A, Doyle JJ, Stern L, et al. Dysfunctional tear syndrome: a Delphi approach to treatment recommendations. Cornea. 2006;25:900-907.
2. DePavia CS, Chen Z, Koch DD, et al. The incidence and risk factors for developing dry eye after myopic LASIK. Am J Ophthalmol. 2006;141:438-445.
3. Hovanesian JA, Shah SS, Maloney RK. Symptoms of dry eye and recurrent erosion syndrome after refractive surgery. J Cataract Refract Surg. 2001;27:577-584.
4. Stern ME, Beuerman RW, Fox RI, et al. The pathology of dry eye: Tthe interaction between the ocular surface and lacrimal glands. Cornea. 1998;17:584-589.
5. Ambrosio R, Tervo T, Wilson SE. LASIK-associated dry eye and neurotrophic epitheliopathy: pathophysiology and strategies for prevention and treatment. J Refract Surg. 2008;24:396-407.
6. Benitez-del-Castillo JM, del Rio T, Iradier T, et al. Decrease in tear secretion and corneal sensitivity after laser in situ keratomileusis. Cornea. 2001;20:30-32.
7. Patel S, Perez-Santonja JJ, Alio JL, et al. Corneal sensitivity and some properties of the tear film after laser in situ keratomileusis. J Refract Surg. 2001;17:17-24.
8. Nasaralla BA, McLeod SD, Nassaralla JJ Jr. Effect of myopic LASIK on human corneal sensitivity. Ophthalmology. 2003;110:497-502.
9. Erie JC, McLaren JW, Hodge DO, et al. Recovery of corneal subbasal nerve density after PRK and LAISK. Am J Ophthalmol. 2005;140:1059-1064.
10. Albietz JM, Lenton LM. Management of the ocular surface and tear film before, during, and after laser in situ keratomileusis. J Refract Surg. 2004;20:62-71.
11. Pflugfleder SC. Anti-inflammatory therapy for dry eye. Am J Ophthalmol. 2004;137: 337-342.
12. Miljanovic B, Trivedi KA, Dana MR, et al. Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women. Am J Clinical Nutr. 2005;82:887-893.
13. Muller LJ, Marfurt CF, Kruse F, et al. Corneal nerves: structure, contents, and function. Exp Eye Res. 2003;76:521-542.
14. Salib GM, McDonald MB, Smolek M. Safety and efficacy of cyclosporine 0.05%drops versus unpreserved artificial tears in dry eye patients having laser in situ keratomileusis. J Cataract Refract Surg. 2006;32:772-778.
15. Peyman GA, Sanders DR, Battle JF, et al. Cyclosporine 0.05%ophthalmic preparation to aid recovery from loss of corneal sensitivity after LASIK. J Refract Surg. 2008;24: 337-343.
16. Noda-Tsuruya T, Asano-Kato N, Toda I, et al. Autologous serum eye drops for dry eye after LASIK. J Refract Surg. 2006;22:61-66.
17. Pepose JS, Johnson EM Jr. Is there a role for neurotrophin treatment of the ocular surface following laser in situ keratomileusis (LASIK)? Am J Ophthalmol. 2005;139: 1090-1094.